Das P C, McElroy W K, Cooper R L
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Toxicol Sci. 2001 Jan;59(1):127-37. doi: 10.1093/toxsci/59.1.127.
The effects of four major chlorotriazine metabolites on the constitutive synthesis of the catecholamines dopamine (DA) and norepinephrine (NE) were examined, using undifferentiated PC12 cells. NE release and intracellular DA and NE concentrations were quantified, for up to 24 h after initiation of treatment with different concentrations, ranging from 0 to 400 microM, of the metabolites hydroxyatrazine (HA), 2-amino-4-chloro-6-isopropylamino-s-triazine (deethylchlorotriazine), 2-amino-4-chloro-6-ethylamino-s-triazine (deisopropylchlorotriazine), and diaminochlorotriazine (DACT). Hydroxyatrazine significantly decreased intracellular DA and NE concentrations in a dose- and time-dependent manner. This metabolite also caused a significant inhibition of NE release from the cells. In contrast, deethylchlorotriazine and deisopropylchlorotriazine significantly increased intracellular DA concentration following exposure to 50-200 microM from 12 to 24 h. Intracellular NE was significantly reduced at these same concentrations of deethylchlorotriazine at 24 h while the concentration of NE in PC12 cells exposed to deisopropylchlorotriazine was not altered at any dosage or time point measured. NE release was decreased at 18 (200 microM) and 24 h (100 and 200 microM) following exposure to deethylchlorotriazine and at 24 h (100 and 200 microM) following deisopropylchlorotriazine. DACT, at the highest concentration (160 microM), significantly increased intracellular DA and NE concentrations at 18 and 24 h. NE release was also increased at 40-160 microM at 24 h. The viability of the PC12 cells was tested using the trypan blue exclusion method. Following 18 to 24 h of treatments with HA, cell viability was reduced 10-12% at the two higher concentrations (200 and 400 microM), but, with other metabolites, the viability was reduced by only 2 to 5% at the highest concentrations. These data indicate that HA affects catecholamine synthesis and release in PC12 cells in a manner that is similar to synthesis of atrazine and simazine. On the other hand, deethylchlorotriazine and deisopropylchlorotriazine altered catecholamine synthesis in a manner similar to that observed in the rat brain following in vivo exposure (i.e., increased DA and decreased NE concentration), whereas DACT appeared to produce an increase in NE release as well as in the intracellular DA and NE concentrations. Overall, these findings suggest that the catecholamine neurons may be a target for the chlorotriazines and/or their metabolites, that the metabolites produce a unique pattern of catecholamine response, and that all of the changes were seen within the same range of doses.
利用未分化的PC12细胞,研究了四种主要氯代三嗪代谢物对儿茶酚胺多巴胺(DA)和去甲肾上腺素(NE)组成型合成的影响。在用不同浓度(0至400微摩尔)的代谢物羟基莠去津(HA)、2-氨基-4-氯-6-异丙基氨基-s-三嗪(去乙基氯代三嗪)、2-氨基-4-氯-6-乙氨基-s-三嗪(去异丙基氯代三嗪)和二氨基氯代三嗪(DACT)处理开始后的长达24小时内,对NE释放以及细胞内DA和NE浓度进行了定量。羟基莠去津以剂量和时间依赖性方式显著降低细胞内DA和NE浓度。这种代谢物还导致细胞NE释放受到显著抑制。相比之下,去乙基氯代三嗪和去异丙基氯代三嗪在暴露于50 - 200微摩尔、12至24小时后显著增加细胞内DA浓度。在24小时时,相同浓度的去乙基氯代三嗪使细胞内NE显著降低,而在任何测量的剂量或时间点,暴露于去异丙基氯代三嗪的PC12细胞中NE浓度均未改变。暴露于去乙基氯代三嗪后,在18小时(200微摩尔)和24小时(100和200微摩尔)时NE释放减少,暴露于去异丙基氯代三嗪后在24小时(100和200微摩尔)时NE释放减少。DACT在最高浓度(160微摩尔)时,在18和24小时显著增加细胞内DA和NE浓度。在24小时时,40 - 160微摩尔的DACT也使NE释放增加。使用台盼蓝排斥法测试PC12细胞的活力。在用HA处理18至24小时后,两个较高浓度(200和400微摩尔)下细胞活力降低10 - 12%,但对于其他代谢物,在最高浓度下活力仅降低2至5%。这些数据表明,HA以类似于莠去津和西玛津合成的方式影响PC12细胞中的儿茶酚胺合成和释放。另一方面,去乙基氯代三嗪和去异丙基氯代三嗪改变儿茶酚胺合成的方式类似于大鼠脑在体内暴露后观察到的方式(即DA增加而NE浓度降低),而DACT似乎导致NE释放以及细胞内DA和NE浓度增加。总体而言,这些发现表明儿茶酚胺神经元可能是氯代三嗪及其代谢物的作用靶点,代谢物产生独特的儿茶酚胺反应模式,并且所有变化都在相同的剂量范围内出现。